K. Sarker

发表

Thromboprophylaxis in Hip Fracture Surgery: A Pilot Study Comparing Danaparoid, Enoxaparin and Dalteparin

J. Finsterer, V. Kakkar, T. Nakajima, 1999, Pathophysiology of Haemostasis and Thrombosis.

Sumoylated SnoN Represses Transcription in a Promoter-specific Manner*

I. Pot, K. Sarker, A. Chan, 2006, Journal of Biological Chemistry.

Anandamide induces apoptosis of PC‐12 cells: involvement of superoxide and caspase‐3

Soichi Obara, M. Nakata, I. Kitajima, 2000, FEBS letters.

ING2 as a Novel Mediator of Transforming Growth Factor-β-dependent Responses in Epithelial Cells*

I. Pot, K. Riabowol, A. Bonni, 2008, Journal of Biological Chemistry.

ODF1 Phosphorylation by Cdk5/p35 Enhances ODF1-OIP1 Interaction

K. Sarker, J. Rosales, Ki-Young Lee, 2007, Cellular Physiology and Biochemistry.

Ebselen inhibits NO‐induced apoptosis of differentiated PC12 cells via inhibition of ASK1‐p38 MAPK‐p53 and JNK signaling and activation of p44/42 MAPK and Bcl‐2

I. Maruyama, T. Hashiguchi, K. Yamaji, 2003, Journal of neurochemistry.

The role of thrombin in the neo-vascularization of malignant gliomas: an intrinsic modulator for the up-regulation of vascular endothelial growth factor.

J. Kuratsu, M. Nakata, H. Takeshima, 2002, International journal of oncology.

Inhibitory effect of epigallocatechin-gallate on brain tumor cell lines in vitro.

J. Kuratsu, K. Sarker, H. Hirano, 2001, Neuro-oncology.

Inhibition of caspase-3 activation by SB 203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells

T. Nakajima, M. Nakata, I. Maruyama, 2000, Journal of Molecular Neuroscience.

Inhibition of Thrombin-induced Neuronal Cell Death by Recombinant Thrombomodulin and E5510, a Synthetic Thrombin Receptor Signaling Inhibitor

T. Nakajima, M. Nakata, I. Maruyama, 1999, Thrombosis and Haemostasis.

Identification of a Novel Function for the Chromatin Remodeling Protein ING2 in Muscle Differentiation

K. Riabowol, K. Sarker, A. Chan, 2012, PloS one.

Neuropeptide Release from Dental Pulp Cells by RgpB via Proteinase-Activated Receptor-2 Signaling

M. Torii, I. Maruyama, S. Tancharoen, 2005, The Journal of Immunology.

Membrane cholesterol but not putative receptors mediates anandamide‐induced hepatocyte apoptosis

M. Yamakuchi, I. Maruyama, K. Kawahara, 2003, Hepatology.

Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts

I. Maruyama, K. Sarker, 2003, Cellular and Molecular Life Sciences CMLS.

L6 myoblast differentiation is modulated by Cdk5 via the PI3K–AKT–p70S6K signaling pathway

K. Sarker, Ki-Young Lee, 2004, Oncogene.

Outer Dense Fibers Serve as a Functional Target for Cdk5·p35 in the Developing Sperm Tail*

R. Oko, Y. Jeong, K. Sarker, 2004, Journal of Biological Chemistry.

Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH‐7) through the activation of JNK1/2 and the downregulation of Akt

I. Maruyama, K. Kawahara, T. Hashiguchi, 2006, FEBS letters.

Anti-atherogenic effects of an egg yolk-enriched garlic supplement

I. Maruyama, K. Yamaji, K. Abeyama, 2004, International journal of food sciences and nutrition.

Anandamide induces apoptosis in human endothelial cells: its regulation system and clinical implications

M. Yamakuchi, I. Maruyama, K. Kawahara, 2003, Thrombosis and Haemostasis.

Polymyxin B binds to anandamide and inhibits its cytotoxic effect

M. Akashi, M. Nakata, I. Maruyama, 2000, FEBS letters.

Antioxidant effects of 1,5-anhydro-D-fructose, a new natural sugar, in vitro.

S. Hizukuri, I. Maruyama, K. Yamaji, 2002, Planta medica.

Recombinant Thrombomodulin Inhibits Thrombin-Induced Vascular Endothelial Growth Factor Production in Neuronal Cells

T. Nakajima, M. Nakata, I. Maruyama, 1999, Pathophysiology of Haemostasis and Thrombosis.

ASK1–p38 MAPK/JNK signaling cascade mediates anandamide‐induced PC12 cell death

M. Yamakuchi, M. Kracht, I. Maruyama, 2003, Journal of neurochemistry.

Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region

I. Maruyama, K. Arimura, T. Hashiguchi, 2003, Journal of thrombosis and haemostasis : JTH.

SnoN Is a Cell Type-specific Mediator of Transforming Growth Factor-β Responses*

Sylvia M. Wilson, K. Sarker, S. Bonni, 2005, Journal of Biological Chemistry.

Bioactivity of the Vascular Endothelial Growth Factor Trapped in Fibrin Clots: Production of IL-6 and IL-8 in Monocytes by Fibrin Clots

M. Nasu, I. Maruyama, I. Kitajima, 2001, Pathophysiology of Haemostasis and Thrombosis.

The agonist of the protease-activated receptor-1 (PAR1) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human vascular smooth muscle cells

M. Nakata, I. Maruyama, I. Kitajima, 2003, Cellular and Molecular Life Sciences CMLS.

Inhibition of Human Breast Cancer Cell Proliferation by Low‐Intensity Ultrasound Stimulation

Lijie Grace Zhang, Kausik Sarkar, K. Sarker, 2020, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

SnoN is a cell type-specific mediator of transforming growth factor-beta responses.

Sylvia M. Wilson, K. Sarker, S. Bonni, 2005, The Journal of biological chemistry.

Inhibition of Thrombin-Induced Vascular Endothelial Growth Factor Production in Human Neuroblastoma (NB-1) Cells by Argatroban

M. Yamakuchi, I. Maruyama, T. Hashiguchi, 2005, Pathophysiology of Haemostasis and Thrombosis.

Thrombin Enhances NGF-Mediated Neurite Extension via Increased and Sustained Activation of p44/42 MAPK and p38 MAPK

Songbin Fu, K. Sarker, J. Rosales, 2014, PloS one.

Increased production of vascular endothelial growth factor (VEGF) by angiotensin II in neuro-2A cells

T. Nakajima, M. Nakata, I. Maruyama, 1999 .

ING2 as a Novel Mediator of Transforming Growth Factor-β-dependent Responses in Epithelial Cells*

I. Pot, K. Riabowol, A. Bonni, 2008, Journal of Biological Chemistry.